Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in young children, elderly and immunocompromised patients worldwide. The RSV fusion (F) protein, which has 5–6 N-glycosylation sites depending on the strain, is a major target for vaccine development....
Saved in:
Main Authors: | Lotte Jacobs, Annelies Leemans, Kim Stobbelaar, Axelle Fransen, Paul Cos, Peter Delputte |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/12/1848 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
by: Gengxin Zhang, et al.
Published: (2024-10-01) -
Editorial: How RSV outsmarts the host
by: Stephania A. Cormier, et al.
Published: (2024-12-01) -
Prevention of Lower Respiratory Tract Diseases caused by RSV in Infants in Poland: A Review of Current Recommendations
by: Gabriela Zofia Mierzwa, et al.
Published: (2024-12-01) -
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01) -
Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021–2023 RSV outbreaks to investigate the immunity debt hypothesis
by: Eli A. Piliper, et al.
Published: (2024-12-01)